Literature DB >> 19293054

Predictive factors for non-sentinel lymph node involvement in breast cancer patients with a positive sentinel node: should we consider sentinel node-related factors?

J L Fougo1, M Afonso, F Senhorães Senra, T Dias, C Leal, C Araújo, M Dinis-Ribeiro.   

Abstract

INTRODUCTION: Sentinel node (SN) biopsy to predict axillary involvement in breast cancer patients is a common practice. After a positive SN, additional metastases are present in an unpredictable percentage, as variable as 13-66%, of axillary clearances. Our aim is to define variables associated with non-sentinel node (NSN) metastases and to determine the predictive value of a derived clinical decision rule.
METHODS: A consecutive series of patients with a positive SN submitted to SN biopsy plus axillary dissection was evaluated from June 1999 to December 2004 (n=143). Patient-, tumour- and SN-related variables were analysed in relation to the presence of additional metastasis. Univariate and multivariate analyses were done and predictive values of a clinical decision rule based on significant variables were estimated.
RESULTS: A total of 66 patients had metastasis in non-sentinel axillary nodes. No significant differences were present between this group and those with only the SN metastasised. Significant and independent association was found between NSN positivity and increasing tumour size, the presence of multifocality and the presence of peritumoral lymph channel invasion.
CONCLUSIONS: A first derivation of a simple rule based on tumour-related variables concurs to define the presence of NSN metastasis. Care should be taken when including SNrelated variables in these algorithms.

Entities:  

Mesh:

Year:  2009        PMID: 19293054     DOI: 10.1007/s12094-009-0333-y

Source DB:  PubMed          Journal:  Clin Transl Oncol        ISSN: 1699-048X            Impact factor:   3.405


  35 in total

1.  Non-sentinel lymph node metastases in breast cancer patients with metastatic sentinel nodes.

Authors:  Wai-Ka Hung; Miranda Chi-Mui Chan; Kong-Ling Mak; Sui-Fan Chong; Yvonne Lau; Chiu-Ming Ho; Andrew Wai-Chun Yip
Journal:  ANZ J Surg       Date:  2005 Jan-Feb       Impact factor: 1.872

Review 2.  A concept for the clinical implementation of sentinel lymph node biopsy in patients with breast carcinoma with special regard to quality assurance.

Authors:  Thorsten Kuehn; Andreas Bembenek; Thomas Decker; Dieter Ludwig Munz; Marie-Luise Sautter-Bihl; Michael Untch; Diethelm Wallwiener
Journal:  Cancer       Date:  2005-02-01       Impact factor: 6.860

3.  Factors predicting the sentinel and non-sentinel lymph node metastases in breast cancer.

Authors:  V Ozmen; H Karanlik; N Cabioglu; A Igci; M Kecer; O Asoglu; S Tuzlali; A Mudun
Journal:  Breast Cancer Res Treat       Date:  2006-01       Impact factor: 4.872

4.  Do all patients with sentinel node metastasis from breast carcinoma need complete axillary node dissection?

Authors:  K U Chu; R R Turner; N M Hansen; M B Brennan; A Bilchik; A E Giuliano
Journal:  Ann Surg       Date:  1999-04       Impact factor: 12.969

5.  Sentinel-node biopsy to avoid axillary dissection in breast cancer with clinically negative lymph-nodes.

Authors:  U Veronesi; G Paganelli; V Galimberti; G Viale; S Zurrida; M Bedoni; A Costa; C de Cicco; J G Geraghty; A Luini; V Sacchini; P Veronesi
Journal:  Lancet       Date:  1997-06-28       Impact factor: 79.321

6.  Predictors of positive axillary lymph nodes after sentinel lymph node biopsy in breast cancer.

Authors:  S F Abdessalam; E E Zervos; M Prasad; W B Farrar; L D Yee; M J Walker; W B Carson; W E Burak
Journal:  Am J Surg       Date:  2001-10       Impact factor: 2.565

7.  Sentinel lymph node biopsy with metastasis: can axillary dissection be avoided in some patients with breast cancer?

Authors:  C Reynolds; R Mick; J H Donohue; C S Grant; D R Farley; L S Callans; S G Orel; G L Keeney; T J Lawton; B J Czerniecki
Journal:  J Clin Oncol       Date:  1999-06       Impact factor: 44.544

8.  Predictors of nonsentinel lymph node metastasis in breast cancer patients.

Authors:  Ulka Sachdev; Kara Murphy; Alain Derzie; Shabnam Jaffer; Ira J Bleiweiss; Steven Brower
Journal:  Am J Surg       Date:  2002-03       Impact factor: 2.565

9.  Prediction of tumour involvement in remaining axillary lymph nodes when the sentinel node in a woman with breast cancer contains metastases.

Authors:  C Nos; C Harding-MacKean; P Fréneaux; A Trie; M C Falcou; X Sastre-Garau; K B Clough
Journal:  Br J Surg       Date:  2003-11       Impact factor: 6.939

10.  Multifocality and multicentricity are not contraindications for sentinel lymph node biopsy in breast cancer surgery.

Authors:  Alberta Ferrari; Paolo Dionigi; Francesca Rovera; Luigi Boni; Giorgio Limonta; Silvana Garancini; Diego De Palma; Gianlorenzo Dionigi; Cristiana Vanoli; Mario Diurni; Giulio Carcano; Renzo Dionigi
Journal:  World J Surg Oncol       Date:  2006-11-20       Impact factor: 2.754

View more
  3 in total

1.  Beware the node: the more we know, the less aggressive we are.

Authors:  A Piñero
Journal:  Clin Transl Oncol       Date:  2009-03       Impact factor: 3.405

2.  Analysis of factors related to non-sentinel lymph node metastasis in 296 sentinel lymph node-positive Chinese breast cancer patients.

Authors:  Amina Maimaitiaili; Di Wu; Zhenyu Liu; Haimeng Liu; Xiamusiye Muyiduli; Zhimin Fan
Journal:  Cancer Biol Med       Date:  2018-08       Impact factor: 4.248

3.  A novel nomogram for decision-making assistance on exemption of axillary lymph node dissection in T1-2 breast cancer with only one sentinel lymph node metastasis.

Authors:  Lei Liu; Yaoxin Lin; Guozheng Li; Lei Zhang; Xin Zhang; Jiale Wu; Xinheng Wang; Yumei Yang; Shouping Xu
Journal:  Front Oncol       Date:  2022-09-12       Impact factor: 5.738

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.